$Osteoporosis drugs for prevention of clinical fracture in white postmenopausal women: a network meta-analysis of survival data$

Osteoporosis drugs for prevention of clinical fracture in white postmenopausal women: a network meta-analysis of survival data

Summary By Bayesian random effects network meta-analysis stratified by prevalent vertebral fracture (PVF), we conclude that different effective drugs should be used to prevent fragility fractures according to postmenopausal women with or without PVF and that there are two drugs (i.e., parathyroid ho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Osteoporosis international 2020-05, Vol.31 (5), p.961-971
Hauptverfasser:	Ding, L.-L., Wen, F., Wang, H., Wang, D.-H., Liu, Q., Mo, Y.-X., Tan, X., Qiu, M., Hu, J.-X.
Format:	Artikel
Sprache:	eng
Schlagworte:	Alendronic acid Bayes Theorem Bayesian analysis Bisphosphonates Bone Density Conservation Agents - adverse effects Clinical trials Drugs Endocrinology Female Health risk assessment Humans Medicine Medicine & Public Health Meta-analysis Monoclonal antibodies Network Meta-Analysis Original Article Orthopedics Osteoporosis Osteoporosis, Postmenopausal - complications Osteoporosis, Postmenopausal - drug therapy Osteoporotic Fractures - prevention & control Parathyroid Parathyroid hormone Pharmaceutical Preparations Post-menopause Postmenopause Rheumatology Risedronic acid Vertebrae Zoledronic acid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!